Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
- 28 February 2011
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 57 (2), 235-244
- https://doi.org/10.1053/j.ajkd.2010.08.036
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisJournal of the American Society of Nephrology, 2009
- Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus NephritisThe New England Journal of Medicine, 2005
- Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus NephritisThe New England Journal of Medicine, 2000
- Factors predictive of outcome in severe lupus nephritisAmerican Journal of Kidney Diseases, 2000
- Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus NephritisAnnals of Internal Medicine, 1996
- Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide TherapyAnnals of Internal Medicine, 1993
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- A Controlled Trial of Plasmapheresis Therapy in Severe Lupus NephritisThe New England Journal of Medicine, 1992
- Long‐term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone onlyArthritis & Rheumatism, 1991
- Therapy of Lupus NephritisThe New England Journal of Medicine, 1986